|
Gallego P, Roldan V, Marín F, Romera M, Valdés M, Vicente V, Lip GY. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation. Thromb Haemost. 2013 Dec;110(6):1189-98. doi: 10.1160/TH13-07-0556. PubMed PMID: 24096615.
AÑO: 2013; IF: 5.76
|
24096615
|
Roldán V, Marín F, Manzano-Fernandez S, Fernández H, Gallego P, Valdés M, Vicente V, Lip GY. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation? Thromb Haemost. 2013 May;109(5):956-60. doi: 10.1160/TH13-01-0054. PubMed PMID: 23572113.
AÑO: 2013; IF: 5.76
|
|
Roldán V, Marín F, Fernández H, Manzano-Fernández S, Gallego P, Valdés M, Vicente V, Lip GY. Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding). Am J Cardiol. 2013 Apr 15;111(8):1159-64. doi: 10.1016/j.amjcard.2012.12.045. PubMed PMID: 23337836.
AÑO: 2013; IF: 3.425
|
|
Anton AI, Cerezo-Manchado JJ, Padilla J, Perez-Andreu V, Corral J, Vicente V, Roldan V, Gonzalez-Conejero R. Novel associations of VKORC1 variants with higher acenocoumarol requirements. PLoS One. 2013 May 17;8(5):e64469. doi: 10.1371/journal.pone.0064469. PubMed PMID: 23691226; PubMed Central PMCID: PMC3656883.
AÑO: 2013; IF: 3.534
|
|
Navarro S, Medina P, Bonet E, Corral J, Martínez-Sales V, Martos L, Rivera M, Roselló-Lletí E, Alberca I, Roldán V, Mira Y, Ferrando F, Estellés A, Vicente V, Bertina RM, España F. Association of the thrombomodulin gene c.1418C>T polymorphism with thrombomodulin levels and with venous thrombosis risk. Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1435-40. doi: 10.1161/ATVBAHA.113.301360. PubMed PMID: 23520161.
AÑO: 2013; IF: 5.533
|